Tamiflu (oseltamivir) is considered safe to take while breastfeeding. It is the CDC’s preferred antiviral for breastfeeding women with suspected or confirmed flu, and the amount that passes into breast milk is far too low to affect a nursing infant.
How Much Reaches Your Baby Through Breast Milk
Tamiflu and its active byproduct do appear in breast milk, but at levels that are a tiny fraction of what would be needed to have any effect on an infant. A pharmacokinetic study published in the American Journal of Obstetrics & Gynecology found that the drug shows up in milk later and at lower concentrations than in the mother’s bloodstream. The concentrations were “significantly lower than considered therapeutic in infants,” meaning your baby would receive nowhere near enough to constitute a dose.
The most useful way to measure this is through something called the relative infant dose, which compares what a baby gets through milk to a weight-adjusted version of the mother’s dose. For Tamiflu, that number is remarkably small. One study calculated it at 0.5% of the maternal dose. A more recent analysis put it even lower, at less than 0.1% compared to a therapeutic infant dose. In lactation safety, anything under 10% is generally considered acceptable. Tamiflu doesn’t come close to that threshold.
What Health Authorities Recommend
The CDC explicitly names oral oseltamivir as the preferred antiviral for breastfeeding women with the flu, noting that it “is not easily passed to the infant in breast milk” and that “adverse effects [are] unlikely.” The recommendation applies to both influenza A and influenza B.
The CDC also recommends antiviral treatment for women up to two weeks postpartum, including after pregnancy loss, if they have suspected or confirmed influenza of any severity. This reflects how seriously health authorities take flu complications in the postpartum period. Delaying or skipping treatment to protect your milk supply carries more risk than taking the medication. Tamiflu works best when started within 48 hours of symptom onset, so prompt treatment matters.
Should You Keep Breastfeeding While Sick?
Yes. Having the flu is not a reason to stop nursing. Your breast milk actually provides your baby with antibodies your body produces in response to the infection. The bigger concern is direct contact: washing your hands frequently, wearing a mask while feeding, and avoiding coughing or sneezing near your baby will reduce the chance of passing the virus along through respiratory droplets.
Other Flu Antivirals and Breastfeeding
Not all flu medications have the same safety profile during breastfeeding. Zanamivir (Relenza), an inhaled antiviral, is also used in some cases, though oseltamivir remains the first choice because it’s taken orally and has more data behind it in breastfeeding women.
Baloxavir (Xofluza), a newer single-dose antiviral, is a different story. The CDC does not recommend it for breastfeeding women because there is no data on whether it appears in human milk, how it might affect a nursing infant, or whether it influences milk production. If you’re breastfeeding and prescribed a flu antiviral, Tamiflu is the established option with a clear safety record.
What to Expect When Taking Tamiflu
The standard course is twice daily for five days. The most common side effects for the mother are nausea and vomiting, which typically improve if you take the medication with food. These side effects do not transfer to your baby through breast milk. Given the extremely low drug concentrations found in milk, no adverse effects in breastfed infants have been linked to maternal Tamiflu use.
If you’ve been exposed to someone with confirmed flu but aren’t yet sick, Tamiflu can also be used preventively. The CDC notes that preventive antiviral treatment can be considered for postpartum women who have had close contact with an infectious person, since this population faces higher risks from influenza complications.